Pneumagen

About Pneumagen

Pneumagen is a clinical-stage biotech company focused on revolutionizing the management of viral respiratory tract infections. Their mission is to develop innovative, life-saving, broad-spectrum antiviral therapies for the prevention and treatment of infections in at-risk patients vulnerable to a wide range of respiratory tract infections.

Products & Services

Neumifil:A novel, engineered multivalent Carbohydrate Binding Module (mCBM) developed as a broad-spectrum intranasal drug for the prophylaxis and treatment of viral respiratory infections, including Influenza Virus, Respiratory Syncytial Virus, Human Rhinovirus, and Coronavirus Infections (including SARS-CoV-2). It has shown clinically significant results in reducing symptomatic influenza incidence and symptom severity in a Phase 2 study.

Specialties

Viral respiratory tract infections Broad-spectrum antiviral therapies Intranasal drug development Chronic Obstructive Pulmonary Disease (COPD) treatments

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Financing Round T: - FT: Financing Round	A: 9920000 MR: - FA: £8 million FAN: 9920000	D: 2023-06-01 FD: 2023-06-01	5 investors

Financing Round Latest

2023-06-01

$9.9M

5 investors (Pro only)

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

J

James Chalmers

Asthma and Lung UK Chair of Respiratory Research

S

Sanjay Haresh Chotirmall

Associate Professor and Provost's Chair of Molecular Medicine

C

Charles Haworth

Consultant Respiratory Physician and Chairman of the Clinical Advisory Group

P

Peter Wark

Senior Staff Specialist in Respiratory and Sleep Medicine and Conjoint Professor

K

Kevin Winthrop

Professor

D

Douglas Thomson

Chief Executive Officer

View 13 more team members with Pro

Unlock Full Team Directory

Recent News

Pneumagen Announces New Product Launch

2 days ago

Company unveils innovative solution to transform the industry, expanding market reach and capabilities...

Leadership Team Expands with Industry Veteran

1 week ago

New executive brings 20+ years of experience to accelerate growth and strategic initiatives...

Company Recognized as Industry Leader

2 weeks ago

Receives prestigious award for innovation and customer satisfaction in competitive market...

Key Competitors

C1

Competitor Alpha

Series B · $50M raised

C2

Competitor Beta

Series C · $120M raised

C3

Competitor Gamma

Series A · $25M raised

C4

Competitor Delta

Seed · $10M raised